MENU
CLYM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Climb Bio (CLYM) Earnings Date & Reports
Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases... Show more
A.I. Advisor
published Earnings
CLYM is expected to report earnings to rise 9.15% to -21 cents per share on August 18
Q2'26
Est.
$-0.22
Q1'26
Beat
by $0.09
Q4'25
Missed
by $0.07
Q3'25
Missed
by $0.04
Q2'25
Beat
by $0.05
The last earnings report on May 07 showed earnings per share of -20 cents, beating the estimate of -28 cents. With 636.67K shares outstanding, the current market capitalization sits at 675.70M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information